Although it cannot represent all the SRCC, the frequency of such fusion is much higher than most of the reported driver mutated and druggable genes in tumorigenesis in other types/subtypes of cancers (e.g., ALK fusion), indicating its important role on tumorigenesis of SRCC. The gene discussed is ALK; the disease is cancer.